Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media
- PMID: 16928889
- PMCID: PMC1595316
- DOI: 10.1128/CVI.00257-06
Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media
Abstract
Pneumococcal neuraminidase, NanA, is a pneumococcal vaccine candidate. Prior culture-confirmed pneumococcal contacts were shown to induce serum anti-NanA antibodies during the first 2 years of life. The antibody concentrations at neither 12 nor 18 months were significantly associated with the risk of subsequent pneumococcal carriage or acute otitis media.
Figures
References
-
- Bogaert, D., E. Holmlund, M. Lahdenkari, R. de Groot, T. Kilpi, P. W. Hermans, and H. Kayhty. 2006. Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media. FEMS Immunol. Med. Microbiol. 46:166-168. - PubMed
-
- Holmlund, E., T. Jaakkola, L. Saarinen, M. Lahdenkarin, J. Hamel, B. Brodeur, T. M. Kilpin and H. Käyhty. 2004. Abstr. 4th Int. Symp. on Pneumococci Pneumococcal Dis., abstr. IMM-26.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
